Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study

被引:196
作者
Gong, Q. [1 ,5 ]
Gregg, E. W. [2 ]
Wang, J. [3 ]
An, Y. [1 ]
Zhang, P. [2 ]
Yang, W. [1 ]
Li, H.
Li, H.
Jiang, Y. [3 ]
Shuai, Y. [1 ]
Zhang, B. [1 ]
Zhang, J. [3 ]
Gerzoff, R. B. [2 ]
Roglic, G. [4 ]
Hu, Y. [3 ]
Li, G. [1 ]
Bennett, P. H. [5 ]
机构
[1] China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China
[2] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA
[3] Da Qing First Hosp, Dept Cardiol, Da Qing, Peoples R China
[4] World Hlth Org, Dept Chron Dis & Hlth Promot, Geneva, Switzerland
[5] NIDDKD, Diabet Epidemiol & Clin Res Sect, NIH, Phoenix, AZ USA
关键词
Diabetic retinopathy; Impaired glucose tolerance; Lifestyle intervention; Nephropathy; Neuropathy; VASCULAR-DISEASE; PREVALENCE; RETINOPATHY; MORTALITY; IGT; MELLITUS; AGE;
D O I
10.1007/s00125-010-1948-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We determined the effects of 6 years of lifestyle intervention in persons with impaired glucose tolerance (IGT) on the development of retinopathy, nephropathy and neuropathy over a 20 year period. In 1986, 577 adults with IGT from 33 clinics in Da Qing, China were randomly assigned by clinic to a control group or one of three lifestyle intervention groups (diet, exercise, and diet plus exercise). Active intervention was carried out from 1986 to 1992. In 2006 we conducted a 20 year follow-up study of the original participants to compare the incidence of microvascular complications in the combined intervention group vs the control group. Follow-up information was obtained on 542 (94%) of the 577 original participants. The cumulative incidence of severe retinopathy was 9.2% in the combined intervention group and 16.2% in the control group (p = 0.03, log-rank test). After adjusting for clinic and age, the incidence of severe retinopathy was 47% lower in the intervention group than the control group (hazard rate ratio 0.53, 95% CI 0.29-0.99, p = 0.048). No significant differences were found in the incidence of severe nephropathy (hazard rate ratio 1.05, 95% CI 0.16-7.05, intervention vs control, p = 0.96) or in the prevalence of neuropathy (8.6% vs 9.1%, p = 0.89) among the 20 year survivors. Lifestyle intervention for 6 years in IGT was associated with a 47% reduction in the incidence of severe, vision-threatening retinopathy over a 20 year interval, primarily due to the reduced incidence of diabetes in the intervention group. However, similar benefits were not seen for nephropathy or neuropathy.
引用
收藏
页码:300 / 307
页数:8
相关论文
共 27 条
[1]   Calculating the number needed to treat for trials where the outcome is time to an event [J].
Altman, DG ;
Andersen, PK .
BRITISH MEDICAL JOURNAL, 1999, 319 (7223) :1492-1495
[2]  
[Anonymous], 1985, World Health Organ Tech Rep Ser, V727, P1
[3]  
[Anonymous], 1991, Ophthalmology, V98, P786
[4]   Diabetic somatic neuropathies [J].
Boulton, AJM ;
Malik, RA ;
Arezzo, JC ;
Sosenko, JM .
DIABETES CARE, 2004, 27 (06) :1458-1486
[5]   10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study [J].
Bray, G. A. ;
Chatellier, A. ;
Duncan, C. ;
Greenway, F. L. ;
Levy, E. ;
Ryan, D. H. ;
Polonsky, K. S. ;
Tobian, J. ;
Ehrmann, D. ;
Matulik, M. J. ;
Clark, B. ;
Czech, K. ;
DeSandre, C. ;
Hilbrich, R. ;
McNabb, W. ;
Semenske, A. R. ;
Goldstein, B. J. ;
Smith, K. A. ;
Wildman, W. ;
Pepe, C. ;
Goldberg, R. B. ;
Calles, J. ;
Ojito, J. ;
Castillo-Florez, S. ;
Florez, H. J. ;
Giannella, A. ;
Lara, O. ;
Veciana, B. ;
Haffner, S. M. ;
Montez, M. G. ;
Lorenzo, C. ;
Martinez, A. ;
Hamman, R. F. ;
Testaverde, L. ;
Bouffard, A. ;
Dabelea, D. ;
Jenkins, T. ;
Lenz, D. ;
Perreault, L. ;
Price, D. W. ;
Steinke, S. C. ;
Horton, E. S. ;
Poirier, C. S. ;
Swift, K. ;
Caballero, E. ;
Jackson, S. D. ;
Lambert, L. ;
Lawton, K. E. ;
Ledbury, S. ;
Kahn, S. E. .
LANCET, 2009, 374 (9702) :1677-1686
[6]   Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO multinational study of vascular disease in diabetes [J].
Chi, ZS ;
Lee, ET ;
Lu, M ;
Keen, H ;
Bennett, PH .
DIABETOLOGIA, 2001, 44 (Suppl 2) :S82-S86
[7]   Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial [J].
Gerstein, H. C. ;
Yusuf, S. ;
Holman, R. R. ;
Bosch, J. ;
Anand, S. ;
Avezum, A. ;
Budaj, A. ;
Chiasson, J. ;
Conget, I. ;
Dagenais, G. ;
Davis, M. ;
Diaz, R. ;
Dinccag, N. ;
Enjalbert, M. ;
Escalante, A. ;
Fodor, G. ;
Hanefeld, M. ;
Hedner, T. ;
Jolly, K. ;
Keltai, M. ;
Laakso, M. ;
Lanas, F. ;
Lonn, E. ;
McQueen, M. ;
Mohan, V. ;
Phillips, A. ;
Piegas, L. ;
Pirags, V. ;
Probstfield, J. ;
Shaw, J. ;
Schmid, I. ;
Teo, K. ;
Zimmet, P. ;
Zinman, B. ;
Gerstein, H. C. ;
Yusuf, S. ;
Bosch, J. ;
Pogue, J. ;
Sheridan, P. ;
Dinccag, N. ;
Hanefeld, M. ;
Hoogwerf, B. ;
Laakso, M. ;
Mohan, V. ;
Shaw, J. ;
Zinman, B. ;
Holman, R. R. ;
Diaz, R. ;
Ahuad Guerrero, R. ;
Albisu, J. .
LANCET, 2006, 368 (9541) :1096-1105
[8]   Mortality trends in men and women with diabetes, 1971 to 2000 [J].
Gregg, Edward W. ;
Gu, Qiuping ;
Cheng, Yiling J. ;
Narayan, Venkat ;
Cowie, Catherine C. .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (03) :149-155
[9]   Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes -: 1999-2000 National Health and Nutrition Examination Survey [J].
Gregg, EW ;
Sorlie, P ;
Paulose-Ram, R ;
Gu, QP ;
Eberhardt, MS ;
Wolz, M ;
Burt, V ;
Curtin, L ;
Engelgau, M ;
Geiss, L .
DIABETES CARE, 2004, 27 (07) :1591-1597
[10]   CORONARY HEART-DISEASE AND DIABETIC-RETINOPATHY IN NEWLY DIAGNOSED DIABETES IN DA-QING, CHINA - THE DA-QING IGT AND DIABETES STUDY [J].
HU, YH ;
PAN, XR ;
LIU, PA ;
LI, GW ;
HOWARD, BV ;
BENNETT, PH .
ACTA DIABETOLOGICA, 1991, 28 (02) :169-173